Charles Schwab Investment Management Inc Greenwich Life Sciences, Inc. Transaction History
Charles Schwab Investment Management Inc
- $519 Billion
- Q2 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Greenwich Life Sciences, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 18,454 shares of GLSI stock, worth $248,021. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,454Holding current value
$248,021% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding GLSI
# of Institutions
35Shares Held
1.01MCall Options Held
0Put Options Held
0-
Black Rock Inc. New York, NY309KShares$4.15 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA268KShares$3.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$1.72 Million0.0% of portfolio
-
Credit Agricole S A87KShares$1.17 Million0.01% of portfolio
-
State Street Corp Boston, MA68.4KShares$919,3360.0% of portfolio
About Greenwich LifeSciences, Inc.
- Ticker GLSI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,848,200
- Market Cap $173M
- Description
- Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who ha...